Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)-Reference-Cited by-同舟云学术

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)

Published:2015-08-07 Issue:12 Volume:4 Page:e1049804
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Becht Etienne,Giraldo Nicolas A,Beuselinck Benoit,Job Sylvie,Marisa Laetitia,Vano Yann,Oudard Stéphane,Zucman-Rossi Jessica,Laurent-Puig Pierre,Sautès-Fridman Catherine,de Reyniès Aurélien,Fridman Wolf Herman

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1049804

Reference37 articles.

1. Cancer Genome Landscapes

2. The immune contexture in human tumours: impact on clinical outcome

3. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

4. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

5. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-based Therapies for Penile Cancer;Urologic Clinics of North America;2024-08

2. Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types;Cancers;2024-04-23

3. Genomic and Transcriptomic Characteristics of Tumors of Patients with Metastatic Clear Cell Renal Cell Carcinoma Clinically Benefiting from First-Line Treatment with Ipilimumab Plus Nivolumab;Kidney Cancer;2023-12-18

4. Caspase recruiting domain-containing protein 11 (CARD11) serves as a therapeutic biomarker for the drug therapies of clear cell renal cell carcinoma;2023-12-06

5. Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma;Cancers;2023-11-29